# Review the trend for a client receiving elacestrant and select the best interpretation and action.

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=522996&lang=en  
> language: en  
> subject: Adverse Effects/Contraindications/Interactions  
> category: PPT

## Question

Review the trend for a client receiving elacestrant and select the best interpretation and action.

| Time | Data |
| --- | --- |
| Baseline | LDL cholesterol 112 mg/dL; triglycerides 158 mg/dL; medication reconciliation complete |
| Month 2 | LDL cholesterol 181 mg/dL; triglycerides 306 mg/dL; no acute symptoms |
| Current | LDL cholesterol 238 mg/dL; triglycerides 514 mg/dL; clarithromycin added at urgent care |

Q1. How should the trend be interpreted?

Expected efficacy requiring no follow-up
Progressive dyslipidemia plus a new interaction risk
Proof that the client needs an extra dose

Q2. Which action is appropriate now?

Give the next dose with grapefruit juice
Wait until the annual visit
Hold the next dose pending prompt prescriber and pharmacist review of the CYP3A4 interaction and lipid-management plan

## Explanation

Progressive hypercholesterolemia and hypertriglyceridemia require follow-up, and a newly added moderate or strong CYP3A4 inhibitor creates an avoidable interaction that can increase elacestrant exposure.

## In-depth explanation

Quick answer
Connect the lipid trend and new CYP3A4 inhibitor to an elacestrant safety review.

Why this is correct
Elacestrant requires lipid assessment before and during therapy. Strong or moderate CYP3A4 inhibitors and inducers should be avoided, so the new interacting prescription must be clarified before another dose.

Easy analogy or mental picture
Build a medication-safety chain: identify the changing cue, connect it to the labeled toxicity or interaction, interrupt preventable exposure, stabilize the client, and verify a measurable response.

Memory hook
Drug, trend, urgent cue, protective action, and reassessment endpoint.

NCLEX decision rule
Choose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.

Why the other choices are wrong
Options that continue a suspect exposure, normalize a labeled danger cue, or delay escalation leave the client at risk.References
1DailyMed: ORSERDU (elacestrant)Lipid monitoring, CYP3A4 inhibitor and inducer avoidance, hepatic impairment, and embryo-fetal risk counseling

## Clinical scenario

Oncology medication-safety review
Verify indication, current assessment, laboratory and oxygen trends, interactions, urgent toxicity cues, authorized action, and measurable follow-up.

## Related questions

- [A client is admitted to the emergency department after ingesting an unknown amount of acet…](https://mymerci.kr/pages/nclex_q.php?qn_id=362720&lang=en)
- [A client with chronic heart failure is prescribed metoprolol 25 mg orally twice daily. Bef…](https://mymerci.kr/pages/nclex_q.php?qn_id=362756&lang=en)
- [A 28-year-old client with type 1 diabetes receives regular insulin 6 units and NPH insulin…](https://mymerci.kr/pages/nclex_q.php?qn_id=362792&lang=en)
- [A client receives IV vancomycin 1 g every 12 hours for MRSA bacteremia. Before the next do…](https://mymerci.kr/pages/nclex_q.php?qn_id=362833&lang=en)
- [A client with bipolar disorder has been taking lithium carbonate 600 mg orally three times…](https://mymerci.kr/pages/nclex_q.php?qn_id=362894&lang=en)
- [A nurse is monitoring a client receiving a continuous IV heparin infusion for pulmonary em…](https://mymerci.kr/pages/nclex_q.php?qn_id=363988&lang=en)
- [A nurse is preparing to initiate a weight-based continuous IV unfractionated heparin infus…](https://mymerci.kr/pages/nclex_q.php?qn_id=364107&lang=en)
- [A nurse is providing discharge teaching to a 65-year-old client newly prescribed warfarin …](https://mymerci.kr/pages/nclex_q.php?qn_id=364872&lang=en)

## Read in another language

- [en](https://mymerci.kr/pages/nclex_q.php?qn_id=522996&lang=en)
- [ko](https://mymerci.kr/pages/nclex_q.php?qn_id=522996&lang=ko)
- [ja](https://mymerci.kr/pages/nclex_q.php?qn_id=522996&lang=ja)
- [zh-TW](https://mymerci.kr/pages/nclex_q.php?qn_id=522996&lang=zh-tw)
- [vi](https://mymerci.kr/pages/nclex_q.php?qn_id=522996&lang=vi)

---

More free questions: [NCLEX-RN Practice](https://mymerci.kr/pages/nclex_bank.php?lang=en)

_For study reference only. Always follow current clinical guidelines and your institution’s protocols._